Another SonoMotion system, Stone Clear, complements Break Wave because it helps clear the kidney of residual fragments ...
The SonoMotion platform will be showcased at booth 1508 during the 2026 American Urological Association meeting.
The Food and Drug Administration has extended the review period for sparsentan in focal segmental glomerulosclerosis (FSGS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results